Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J20J | ISIN: US44934S2068 | Ticker-Symbol: HWT1
NASDAQ
31.03.25
21:45 Uhr
2,040 US-Dollar
-0,090
-4,23 %
1-Jahres-Chart
ICAD INC Chart 1 Jahr
5-Tage-Chart
ICAD INC 5-Tage-Chart

Aktuelle News zur ICAD Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.03.BTIG maintains Buy rating and $3 target on iCAD shares3
19.03.iCAD Non-GAAP EPS of -$0.03 beats by $0.02, revenue of $5.41M beats by $0.69M1
19.03.iCAD, Inc.: iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 202458NASHUA, N.H., March 19, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically...
► Artikel lesen
05.03.iCAD, Inc.: iCAD and RamSoft Announce Partnership to Deliver ProFound AI-Powered Mammography Solutions Across North America2
28.02.iCAD, Inc. (ICAD) and Koios Partner to Enhance AI-Powered Breast Cancer Detection1
ICAD Aktie jetzt für 0€ handeln
26.02.iCAD, Inc.: Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025151NASHUA, N.H. and CHICAGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and Koios Medical, a leader in AI-driven...
► Artikel lesen
21.02.iCAD, Inc. (ICAD): A Bull Case Theory3
19.02.iCAD Shares Unchanged Ahead of Presentations-
19.02.iCAD, Inc.: iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 20251
04.02.Why iCAD Inc (ICAD) Is Skyrocketing So Far In 20255
01.02.iCAD, Inc. (NASDAQ:ICAD) Short Interest Down 14.5% in January1
27.01.iCAD expects Q4 revenue higher than consensus3
27.01.iCAD, Inc.: iCAD Pre-Announces Estimated Q4 2024 Revenue261iCAD to Participate in the BTIG at Snowbird:12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference NASHUA, N.H., Jan. 27, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD)...
► Artikel lesen
11.12.24iCAD, Inc.: SABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations13
26.11.24iCAD, Inc.: iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024126NASHUA, N.H., Nov. 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company"), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking...
► Artikel lesen
12.11.24Earnings Outlook For icad3
12.11.24FDA clears AI-powered breast cancer detection tech from iCad2
12.11.24iCAD erhält FDA-Zulassung für KI-gestütztes Brustkrebserkennungstool5
12.11.24iCAD AI breast cancer detection tool gains FDA approval3
05.11.24iCAD, Inc.: iCAD to Report Third Quarter 2024 Financial Results on November 13, 20243
Seite:  Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1